Clinical trial Recruiting at 1 site Interventional Ages 13 to 18

External oblique intercostal (EOI) block to reduce pain after otoplasty with rib cartilage graft

Official title: Effect of Ultrasound-Guided External Oblique Intercostal Fascial Plane Block in Pediatric Patients Undergoing Otoplasty With Rib Cartilage Graft

Run by Seoul National University Hospital · NCT07262944 · Data updated 2026-11-12

This trial will test whether an ultrasound-guided EOI nerve block with 0.2% ropivacaine reduces opioid use and pain in patients aged 13–18 having otoplasty with rib cartilage graft.

More Postoperative Pain, Acute trials

Quick facts

Study typeInterventional
Ages13 Years to 18 Years
SexAll
Enrollment60 (estimated)
SponsorSeoul National University Hospital
Academic / other
Locations1 site (Seoul)
StatusRecruiting
StartedDecember 1, 2026
Main results expectedJune 1, 2028
Study endsAugust 30, 2028
Registry record updatedDecember 4, 2025
Trial IDNCT07262944 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are 13–18-year-old patients undergoing otoplasty with rib cartilage graft under general anesthesia at Seoul National University Children's Hospital who provide assent and whose parent or guardian provides written informed consent.

Probably not a fit

Patients with known hypersensitivity to ropivacaine or other amide local anesthetics, opioid allergy, local infection at the injection site, unstable vital signs, severe renal or hepatic dysfunction, sepsis, or other conditions judged unsuitable by the investigator are unlikely to receive benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial at Seoul National University Children's Hospital will assign 13–18-year-old patients undergoing otoplasty with rib cartilage graft to receive either an ultrasound-guided external oblique intercostal (EOI) fascial plane block with 0.2% ropivacaine or no block in addition to standard anesthesia and postoperative care. The primary outcome is total opioid consumption in the first 24 hours after surgery. Secondary outcomes include numeric rating scale pain scores, incentive spirometry performance, incidence of atelectasis, and patient satisfaction. The study will determine whether adding the EOI block improves early pain control and respiratory recovery after chest-wall harvest for otoplasty.

Why it matters

Potential benefit: If effective, the EOI block could lower opioid requirements and pain after surgery, speeding recovery and improving satisfaction for adolescent otoplasty patients.

How similar studies have gone: Other interfascial plane blocks and EOI blocks have shown pain-reducing effects in thoracic and chest-wall procedures, but applying an EOI block specifically for pediatric otoplasty with rib graft is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* \- Pediatric patients aged 13 to 18 years undergoing otoplasty with rib cartilage graft under general anesthesia at Seoul National University Children's Hospital
* Written informed consent obtained from parent or legal guardian, and assent from the patient

Exclusion Criteria:

* Unstable vital signs before surgery (heart rate \<50 or \>150 beats/min, systolic blood pressure \<80 mmHg or \>160 mmHg)
* Known hypersensitivity to ropivacaine or other amide-type local anesthetics
* Massive bleeding or shock
* Local infection at the injection site
* Sepsis
* History of allergy to opioid medications
* Severe renal dysfunction (creatinine \>3.0 mg/dL)
* Severe hepatic dysfunction (AST or ALT \>120 U/L)
* Any condition that, in the investigator's opinion, makes the subject unsuitable for study participation

Where it's running

  • Seoul National University Hospital
    Seoul, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.